Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Current Breast Cancer Reports
Erschienen in:

05.08.2023

Immediate Lymphatic Reconstruction in Breast Cancer Treatment: Clinical Trials and State of the Evidence

verfasst von: Sergey G. Toshinskiy, Elizabeth A. Bailey, Graham S. Schwarz

Erschienen in: Current Breast Cancer Reports | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Breast cancer-related lymphedema (BCRL) is a major contributor to morbidity in breast cancer survivors. Immediate lymphatic reconstruction (ILR) has emerged as a promising surgical option for prevention of BCRL. The purpose of this review is to critically evaluate recent literature on ILR in breast cancer patients.

Recent Findings

Short-term outcomes of ILR at most centers have shown low BCRL rates similar to those seen with sentinel lymph node biopsy. Some centers reporting more than 4-year follow-up have demonstrated up to 50–75% BCRL risk reduction following axillary lymph node dissection (ALND). Others have demonstrated equivocal results from ILR. ILR appears to be surgically and oncologically safe.

Summary

ILR continues to be a promising surgical technique to reduce the risk of BCRL following ALND. Ongoing evaluation is needed to characterize the extent of protective effect conferred by ILR.
Literatur
1.
Duggan C, Trapani D, Ilbawi AM, Fidarova E, Laversanne M, Curigliano G, et al. National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis. Lancet Oncol. 2021;22(11):1632–42.CrossRefPubMed
2.
Dayan JH, Ly CL, Kataru RP, Mehrara BJ. Lymphedema: pathogenesis and novel therapies. Annu Rev Med. 2018;29(69):263–76.CrossRef
3.
Pusic AL, Cemal Y, Albornoz C, Klassen A, Cano S, Sulimanoff I, et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv. 2013;7(1):83–92.CrossRefPubMed
4.
Johnson AR, Fleishman A, Granoff MD, Shillue K, Houlihan MJ, Sharma R, et al. Evaluating the impact of immediate lymphatic reconstruction for the surgical prevention of lymphedema. Plast Reconstr Surg. 2021;147(3):373E-381E.CrossRefPubMed
5.
DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15.CrossRefPubMed
6.
Johnson AR, Kimball S, Epstein S, Recht A, Lin SJ, Lee BT, et al. Lymphedema incidence after axillary lymph node dissection: quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach. Ann Plast Surg. 2019;82(4S Suppl 3):S234-41.CrossRefPubMed
7.
McDuff SGR, Mina AI, Brunelle CL, Salama L, Warren LEG, Abouegylah M, et al. Timing of lymphedema after treatment for breast cancer: when are patients most at risk? Int J Radiat Oncol Biol Phys. 2019;103(1):62–70.CrossRefPubMed
8.
• Granoff MD, Pardo JA, Johnson AR, Fleishman A, Tillotson E, Thomson S, et al. Superficial and functional lymphatic anatomy of the upper extremity. Plast Reconstr Surg. 2022;150(4):900–7. Detailed anatomic description of the superficial lymphatic pathways in the upper extremity based on ICG lymphangiography.CrossRefPubMedPubMedCentral
9.
Medina-Rodríguez ME, de-la-Casa-Almeida M, Martel-Almeida E, Ojeda-Cárdenes A, Medrano-Sánchez EM. Visualization of accessory lymphatic pathways, before and after manual drainage, in secondary upper limb lymphedema using indocyanine green lymphography. J Clin Med. 2019;8(11):1917.
10.
Pronin VI, Adamian AA, Zolotarevskiĭ VIa, Rozanov IuL, Savchenko TV. Limfovenoznye anastomozy dlia profilaktiki postmastéktomi- cheskogo oteka verkhneĭ konechnosti [Lymphovenous anastomoses in the prevention of post-mastectomy edema of the arm]. Sov Med. 1989;(4):32–5. (in Russian)
11.
Boccardo F, Casabona F, De Cian F, Friedman D, Villa G, Bogliolo S, et al. Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol. 2009;16(3):703–8.CrossRefPubMed
12.
Boccardo FM, Casabona F, Friedman D, Puglisi M, De Cian F, Ansaldi F, et al. Surgical prevention of arm lymphedema after breast cancer treatment. Ann Surg Oncol. 2011;18(9):2500–5.CrossRefPubMed
13.
Boccardo F, Casabona F, Decian F, Friedman D, Murelli F, Puglisi M, et al. Lymphatic microsurgical preventing healing approach (LYMPHA) for primary surgical prevention of breast cancer-related lymphedema: over 4 years follow-up. Microsurgery. 2014;34(6):421–4.CrossRefPubMed
14.
Feldman S, Bansil H, Ascherman J, Grant R, Borden B, Henderson P, et al. Single institution experience with lymphatic microsurgical preventive healing approach (LYMPHA) for the primary prevention of lymphedema. Ann Surg Oncol. 2015;22(10):3296–301.CrossRefPubMed
15.
Hahamoff M, Gupta N, Munoz D, Lee BT, Clevenger P, Shaw C, et al. A lymphedema surveillance program for breast cancer patients reveals the promise of surgical prevention. J Surg Res. 2019;1(244):604–11.CrossRef
16.
• Schwarz GS, Grobmyer SR, Djohan RS, Cakmakoglu C, Bernard SL, Radford D, et al. Axillary reverse mapping and lymphaticovenous bypass: lymphedema prevention through enhanced lymphatic visualization and restoration of flow. J Surg Oncol. 2019;120(2):160–7. Highlights technical nuances of performing ILR.CrossRefPubMed
17.
Cook JA, Sasor SE, Loewenstein SN, DeBrock W, Lester M, Socas J, et al. Immediate lymphatic reconstruction after axillary lymphadenectomy: a single-institution early experience. Ann Surg Oncol. 2021;28(3):1381–7.CrossRefPubMed
18.
• Granoff MD, Fleishman A, Shillue K, Johnson AR, Ross J, Lee BT, Teller P, James TA, Singhal D. A four-year institutional experience of immediate lymphatic reconstruction. Plast Reconstr Surg. 2023. https://​doi.​org/​10.​1097/​PRS.​0000000000010381​. One of the largest ILR cohorts in the literature.
19.
Herremans KM, Cribbin MP, Riner AN, Neal DW, Hollen TL, Clevenger P, et al. Five-year breast surgeon experience in LYMPHA at time of ALND for treatment of clinical T1–4N1–3M0 breast cancer. Ann Surg Oncol. 2021;28(10):5775–87.CrossRefPubMedPubMedCentral
20.
• Levy AS, Murphy AI, Ishtihar S, Peysakhovich A, Taback B, Grant RT, et al. Lymphatic microsurgical preventive healing approach for the primary prevention of lymphedema: a 4-year follow-up. Plast Reconstr Surg. 2023;151(2):413–20. Retrospective ILR cohort with the longest follow-up.CrossRefPubMed
21.
Buchan G, Cakmakoglu C, Schwarz GS. ICG lymphographic findings following immediate lymphatic reconstruction in breast cancer patients. J Plast Reconstr Aesthet Surg. 2022;75(7):2164–71.CrossRefPubMed
22.
Johnson AR, Tétrault MA, Bravo MG, Girouard V, Laurence R, Lee BT, et al. Novel quantification of real-time lymphatic clearance: immediate lymphatic reconstruction in a large-animal model. Plast Reconstr Surg. 2022;149(1):130–41.CrossRefPubMed
23.
Weinstein B, Le NK, Robertson E, Zimmerman A, Tavares T, Tran T, et al. Reverse lymphatic mapping and immediate microsurgical lymphatic reconstruction reduces early risk of breast cancer-related lymphedema. Plast Reconstr Surg. 2022;149(5):1061–9.CrossRefPubMed
24.
Agrawal J, Mehta S, Goel A, Pande PK, Kumar K. Lymphatic microsurgical preventing healing approach (LYMPHA) for prevention of breast cancer-related lymphedema—a preliminary report. Indian J Surg Oncol. 2018;9(3):369–73.CrossRefPubMedPubMedCentral
25.
Ozmen T, Lazaro M, Zhou Y, Vinyard A, Avisar E. Evaluation of simplified lymphatic microsurgical preventing healing approach (S-Lympha) for the prevention of breast cancer–related clinical lymphedema after axillary lymph node dissection. Ann Surg. 2019;270(6):1156–60.CrossRefPubMed
26.
Johnson A, Feldman S, James T, Spiguel L, Boccardo F, Singhal D. Comment on a letter to the editor regarding “Evaluation of simplified lymphatic microsurgical preventing healing approach (S-LYMPHA) for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection.” Ann Surg. 2019;270(2):e29-30.CrossRefPubMed
27.
Chiang SN, Skolnick GB, Westman AM, Sacks JM, Christensen JM. National outcomes of prophylactic lymphovenous bypass during axillary lymph node dissection. J Reconstr Microsurg. 2022;38(8):613–20.CrossRefPubMed
28.
Shaffer K, Cakmakoglu C, Schwarz GS, ElSherif A, Al-Hilli Z, Djohan R, et al. Lymphedema prevention surgery: improved operating efficiency over time. Ann Surg Oncol. 2020;27(12):4695–701.CrossRefPubMed
29.
Guzzo HM, Valente SA, Schwarz GS, ElSherif A, Grobmyer SR, Cakmakoglu C, et al. Oncologic safety of axillary lymph node dissection with immediate lymphatic reconstruction. Breast Cancer Res Treat. 2022;196(3):657–64.CrossRefPubMed
30.
Chen WF, Knackstedt R. Delayed distally based prophylactic lymphaticovenular anastomosis: improved functionality, feasibility, and oncologic safety? J Reconstr Microsurg. 2020;36(9):E1-2.CrossRefPubMed
Metadaten
Titel
Immediate Lymphatic Reconstruction in Breast Cancer Treatment: Clinical Trials and State of the Evidence
verfasst von
Sergey G. Toshinskiy
Elizabeth A. Bailey
Graham S. Schwarz
Publikationsdatum
05.08.2023
Verlag
Springer US
Erschienen in
Current Breast Cancer Reports / Ausgabe 3/2023
Print ISSN: 1943-4588
Elektronische ISSN: 1943-4596
DOI
https://doi.org/10.1007/s12609-023-00508-z

Weitere Artikel der Ausgabe 3/2023

Fractionation Approaches in Whole Breast RT

The Relevant Work of Breast Cancer Patient Associations in the Search for Quality Access to Care and Guarantee of Rights in Brazil

Radiation Management of DCIS and Elimination of RT in Low-risk Disease

Management of Local–Regional Recurrence of Breast Cancer

Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities

  • Open Access

Pre-operative Radiation and Immunotherapy in the Treatment of Non-metastatic Breast Cancer

Neu im Fachgebiet Onkologie

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Welche Krebserkrankungen bei Zöliakie häufiger auftreten

Eine große Kohortenstudie hat den Zusammenhang zwischen Zöliakie und gastrointestinalen Krebserkrankungen und inflammatorischen Krankheiten untersucht. Neben gastrointestinalen Tumoren ist auch ein nicht solider Krebs häufiger.

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

Sind Menschen mit muskelinvasivem Urothelkarzinom für die neoadjuvante platinbasierte Therapie nicht geeignet oder sprechen sie darauf nicht gut an, ist Pembrolizumab eine adjuvante Alternative: Die krankheitsfreie Lebenszeit wird dadurch mehr als verdoppelt.

Duale Checkpointhemmung gegen Melanome verlängert langfristig das Leben

Im Vergleich zu den Überlebenschancen vor der Einführung von Immuncheckpointhemmern (ICI) ist der Fortschritt durch eine ICI-Kombination mit unterschiedlichen Tagets bei fortgeschrittenem Melanom erstaunlich. Das belegen die finalen Ergebnisse der CheckMate-067-Studie und geben Betroffenen "Hoffnung auf Heilung".

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise